SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-042339
Filing Date
2017-02-14
Accepted
2017-02-14 11:07:55
Documents
1
Group Members
ANTHONY TAMERSAMI W. MNAYMNEH

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO FORM SC 13G/A d341285dsc13ga.htm SC 13G/A 89203
  Complete submission text file 0001193125-17-042339.txt   90920
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45969 | Film No.: 17604390
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1001 BRICKELL BAY DRIVE 27TH FLOOR MIAMI FL 33131
Business Address 1001 BRICKELL BAY DRIVE 27TH FLOOR MIAMI FL 33131 305-379-2322
H.I.G. ONCOGENEX, INC. (Filed by) CIK: 0001444086 (see all company filings)

IRS No.: 980437195 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A